How much funding has Tenvie raised?

Tenvie has raised $200.0M in total funding, most recently a Series A round.

Where is Tenvie headquartered?

Tenvie is headquartered in San Francisco, California, United States.

What industry is Tenvie in?

Tenvie operates in Biotech, Healthcare.

Tenvie

Q: Who are Tenvie's investors?

Tenvie's investors include ARCH Venture Partners, F-Prime Capital, Mubadala Capital.

Homepage

San Francisco, United States · Founded 2025 · $200.0M raised

Biotech

Healthcare

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2025
Business Model: B2B

Website: tenvie.com
Total Funding: $200.0M
Last Round: $200.0M Series AJan 2025
Rounds: 1

About

Tenvie Therapeutics develops precision-engineered small molecule therapies targeting neuroinflammation and cellular dysfunction in neurological and peripheral diseases. Its lead programs TNV262 (CNS-penetrant NLRP3 inhibitor) and TNV108 (SARM1 allosteric inhibitor) are in Phase 1 clinical trials, with discovery-stage programs across related indications.

Summary

Tenvie is a Biotech company based in San Francisco, United States, founded in 2025. It has raised $200.0M in total across 1 round, most recently a $200.0M Series A round in Jan 2025. Investors include ARCH Venture Partners, F-Prime Capital and Mubadala Capital.